GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,712,000 | -86.4% | 12,500 | -92.8% | 0.06% | -87.3% |
| Q4 2020 | $19,943,000 | +37.5% | 172,800 | +16.0% | 0.46% | +34.2% |
| Q3 2020 | $14,507,000 | +97.1% | 149,000 | +148.3% | 0.34% | +37.8% |
| Q2 2020 | $7,362,000 | -58.8% | 60,000 | -64.9% | 0.25% | -59.1% |
| Q4 2019 | $17,871,000 | -42.1% | 170,919 | -36.3% | 0.60% | -62.6% |
| Q3 2019 | $30,881,000 | +171.4% | 268,450 | +306.7% | 1.61% | +180.5% |
| Q2 2019 | $11,378,000 | +24.8% | 66,000 | +22.0% | 0.57% | +13.9% |
| Q1 2019 | $9,119,000 | +87.2% | 54,100 | +8.2% | 0.50% | +29.3% |
| Q4 2018 | $4,870,000 | – | 50,000 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
| Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
| Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
| Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
| Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
| Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
| ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
| AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
| Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
| CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |